Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Cyclophosphamide for SAA and PNH
NCT00004464Phase 2Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Feb 1996
- Primary completion
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide in aplastic anemia, paroxysmal nocturnal hemoglobinuria (PNH), sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Feb 1996; status: completed.
02
Drugs
cyclophosphamide
03
Conditions
aplastic anemiaparoxysmal nocturnal hemoglobinuria (PNH)
Beyond the preview
Go deeper on NCT00004464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004464.